Mercedes Serna-Rodriguez

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 59 publications

Use of Tralokinumab in a Hairdresser With Severe Chronic Hand Eczema and Occupational Allergic Contact Dermatitis.

Use of Tralokinumab in a Hairdresser With Severe Chronic Hand Eczema and Occupational Allergic Contact Dermatitis.

Journal: Contact dermatitis

Published: May 07, 2026

Real-world effectiveness and safety of tralokinumab in moderate-to-severe atopic dermatitis with malignancy, chronic infections, and multimorbidity.

Real-world effectiveness and safety of tralokinumab in moderate-to-severe atopic dermatitis with malignancy, chronic infections, and multimorbidity.

Journal: Dermatology and therapy

Published: April 26, 2026

Dupilumab in Difficult-to-treat Chronic Spontaneous Urticaria: A Real-world Multicentre Cohort Study.

Dupilumab in Difficult-to-treat Chronic Spontaneous Urticaria: A Real-world Multicentre Cohort Study.

Journal: Acta dermato-venereologica

Published: March 11, 2026

Epidemiological, Clinical and Allergic Profile of Patients With Dyshidrotic Eczema (Acute and Recurrent Vesicular Dermatitis): Evaluation of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy (REIDAC).

Epidemiological, Clinical and Allergic Profile of Patients With Dyshidrotic Eczema (Acute and Recurrent Vesicular Dermatitis): Evaluation of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy (REIDAC).

Journal: Contact dermatitis

Published: February 03, 2026

Recalcitrant folliculitis decalvans treated with baricitinib or upadacitinib: a case series.

Recalcitrant folliculitis decalvans treated with baricitinib or upadacitinib: a case series.

Journal: Clinical and experimental dermatology

Published: December 29, 2025

Analysis of the Influence of Sex in 507 Patients With Moderate-to-Severe Atopic Dermatitis. Spanish Atopic Dermatitis Registry (BIOBADATOP).

Analysis of the Influence of Sex in 507 Patients With Moderate-to-Severe Atopic Dermatitis. Spanish Atopic Dermatitis Registry (BIOBADATOP).

Journal: Actas dermo-sifiliograficas

Published: December 26, 2025

Analysis of the Influence of Sex in 507 Patients With Moderate-to-Severe Atopic Dermatitis: Spanish Atopic Dermatitis Registry (BIOBADATOP).

Analysis of the Influence of Sex in 507 Patients With Moderate-to-Severe Atopic Dermatitis: Spanish Atopic Dermatitis Registry (BIOBADATOP).

Journal: Actas dermo-sifiliograficas

Published: December 26, 2025

Real-World Effectiveness and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: A Multicenter Study From Spain.

Real-World Effectiveness and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: A Multicenter Study From Spain.

Journal: International journal of dermatology

Published: October 29, 2025

Epidemiological and Therapeutic Profile in Atopic Dermatitis According to the Involvement on Special Locations. Spanish Atopic Dermatitis Registry (BIOBADATOP).

Epidemiological and Therapeutic Profile in Atopic Dermatitis According to the Involvement on Special Locations. Spanish Atopic Dermatitis Registry (BIOBADATOP).

Journal: Actas dermo-sifiliograficas

Published: October 13, 2025

Clinical Factors Associated With Current Relevance in Allergic Contact Dermatitis: Development of Predictive Models Based on Data From the Spanish Contact Dermatitis Register (REIDAC).

Clinical Factors Associated With Current Relevance in Allergic Contact Dermatitis: Development of Predictive Models Based on Data From the Spanish Contact Dermatitis Register (REIDAC).

Journal: Contact dermatitis

Published: October 09, 2025

The Changing Spectrum of Pediatric Allergic Contact Dermatitis: A Prospective Multicentric Study in Spain.

The Changing Spectrum of Pediatric Allergic Contact Dermatitis: A Prospective Multicentric Study in Spain.

Journal: Dermatitis : contact, atopic, occupational, drug

Published: August 18, 2025

Delayed hypersensitivity reaction after mesotherapy with phosphatidylcholine-based lipolytic solution.

Delayed hypersensitivity reaction after mesotherapy with phosphatidylcholine-based lipolytic solution.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: August 14, 2025

Showing 1-12 of 59

Last Updated: 09/26/2026